Dr Reddys Laboratories Ltd

Newspaper Publication

Copies of newspaper publication

Company Update / Newspaper Publication View filing →

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund

Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2105

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2105

Company Update / General View filing →

Clarification-Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Clarification sought from Dr Reddys Laboratories Ltd

The Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28, 2026, (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) ....

Company Update / Clarification

Analyst / Investor Meet - Outcome

Transcript of Earnings call recording

Company Update / Analyst / Investor Meet View filing →

Newspaper Publication

Copy of newspaper publication

Company Update / Newspaper Publication View filing →

Shareholder Meeting / Postal Ballot-Outcome of AGM

Outcome of 42nd Annual General Meeting

AGM/EGM / AGM View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Scrutinizer's Report

AGM/EGM / AGM View filing →

Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Grant of Employee Stock Options

Company Update / General View filing →

Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Conference Call Transcript

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015- Conference Call Transcript

Company Update / General View filing →

Analyst / Investor Meet - Outcome

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / Analyst / Investor Meet View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Analyst / Investor Meet - Intimation

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / Analyst / Investor Meet View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg 74(5) of SEBI (Depositories and Participants), Regulations, 2018

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Newspaper Publication

Please find enclosed copy of Newspaper Publication

Company Update / Newspaper Publication View filing →

Newspaper Publication

Please find enclosed copy of Newspaper Publication

Company Update / Newspaper Publication View filing →

Reg. 34 (1) Annual Report.

Please find enclosed Integrated Annual Report FY 2025-26

Others / Reg. 34 (1) Annual Report View filing →

Notice Of The 42Nd Annual General Meeting Scheduled On July 23, 2026.

Please find enclosed Notice of the 42nd Annual General Meeting of the Company.

AGM/EGM / AGM View filing →

Business Responsibility and Sustainability Reporting (BRSR)

Please find enclosed Business Responsibility and Sustainability Report FY 2026

Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →

Letter To Shareholders In Relation To Integrated Annual Report Of The Company For FY 2025-26

Please find enclosed letter to shareholder in relation to Integrated Annual Report of the Company for FY 2025-26

Company Update / General View filing →

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015

Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Company Update / General View filing →

Board Meeting Intimation for Considering The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending On June 30, 2026

Dr Reddys Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2026 ,inter alia, to consider and approve the Un-audited Standalone ....

Board Meeting / Board Meeting View filing →

Closure of Trading Window

Intimation regarding Closure of Trading window

Insider Trading / SAST / Closure of Trading Window View filing →

Allotment of ESOP / ESPS

Allotment of Employee Stock options

Company Update / Allotment of ESOP / ESPS View filing →

Newspaper Publication

Copies of newspaper publication

Company Update / Newspaper Publication View filing →

Analyst / Investor Meet - Intimation

Intimation of analyst meet

Company Update / Analyst / Investor Meet View filing →

Allotment of ESOP / ESPS

Allotment of Employee Stock Options

Company Update / Allotment of ESOP / ESPS View filing →

Analyst / Investor Meet - Intimation

Intimation of Analyst/Investor meet

Company Update / Analyst / Investor Meet View filing →